Showing results (591-600 of 641) with videos related to
Sort By:
Pageof 65
Acta Medica Okayama|December 22, 2022
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer PatientsYuko Abe, Naruto Taira, Kosuke Kashiwabara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung CancerHirotsugu Kenmotsu, Nobuyuki Yamamoto, Toshihiro Misumi, et al.Annals of Surgical Oncology|June 24, 2023
EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After SurgeryToshiya Fujiwara, Kazuhiko Shien, Motoki Matsuura, et al.Cancer Research|December 4, 2002
Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinomaFumiaki Sato, David Shibata, Noam Harpaz, et al.Breast Cancer (Tokyo, Japan)|November 13, 2020
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese womenKengo Kawada, Naruto Taira, Taeko Mizoo, et al.Pathology International|September 21, 2020
Multiplex gene-panel testing for lung cancer patientsYasushi Yatabe, Kuniko Sunami, Koichi Goto, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2022
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in AsiaTetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2020
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung CancerHirotsugu Kenmotsu, Nobuyuki Yamamoto, Takeharu Yamanaka, et al.General Thoracic and Cardiovascular Surgery|May 17, 2021
Current status of inhaled nitric oxide therapy for lung transplantation in Japan: a nationwide surveyNobuyuki Yoshiyasu, Masaaki Sato, Daisuke Nakajima, et al.Chest|May 11, 2019
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka, et al.Pageof 65